Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a $3 billion market cap pharmaceutical company specializing in the development of therapeutic drugs, announced today the departure of its Chief Commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback